- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01285986
Scandinavian Miller Collar Study (SCAMICOS)
January 27, 2011 updated by: University Hospital, Linkoeping
Randomized study to evaluate the effect of adding a vein collar at the distal anastomosis to PTFE-grafts used for bypass to below knee arteries in patients with critical limb ischemia with respect to primary patency, secondary patency, and limb salvage
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
352
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Linköping, Sweden, 581 85
- Department of CardioVascular Surgery, University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Critical limb ischemia
- Need for bypass surgery
Exclusion Criteria:
- Can not participate in follow-up
- Has suitable saphenous vein
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Vein collar at distal anastomosis
Vein collar at the distal anastomosis
|
Vein collar interposed at the distal anastomosis or No vein collar interposed at the distal anastomosis
|
Experimental: No vein collar at the distal anastomosis
|
Vein collar interposed at the distal anastomosis or No vein collar interposed at the distal anastomosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary graft patency
Time Frame: Up to five years
|
Follow-up at 1, 3, 6, and 12. Thereafter at most 5 years or until death of patient or amputation of limb.
Primary graft patency = patent graft without any intervention to open up or prevent a graft ocklusion.
Methods used for verification of patency: angiography, duplex, an improved ankle-brachial index was mantained, palpable pulse, or bi- or triphasic Doppler signal over the graft.
|
Up to five years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Secondary Patency
Time Frame: Up to five years
|
Secondary patency = patent graft after one or several interventions to open up or prevent a graft occlusion.
Methods used for verification of secondary patency: angiography, duplex, an improved ankle-brachial index was mantained, palpable pulse, or bi- or triphasic Doppler signal over the graft.
|
Up to five years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Fredrik BG Lundgren, MD, PhD, Department of CardioVascular Surgery, University Hospital, Linköping, Sweden
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 1995
Primary Completion (Actual)
June 1, 1998
Study Completion (Actual)
June 1, 1998
Study Registration Dates
First Submitted
January 27, 2011
First Submitted That Met QC Criteria
January 27, 2011
First Posted (Estimate)
January 28, 2011
Study Record Updates
Last Update Posted (Estimate)
January 28, 2011
Last Update Submitted That Met QC Criteria
January 27, 2011
Last Verified
January 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SCAMICOS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Limb Ischemia
-
R3 Vascular Inc.RecruitingCritical Limb Ischemia | Critical Lower Limb Ischemia | Critical Limb-Threatening IschemiaAustralia
-
Fudan UniversityActive, not recruiting
-
University Health Network, TorontoUnknown
-
Changi General HospitalCompletedCritical Limb IschemiaSingapore
-
AnGes USA, Inc.TerminatedCritical Limb IschemiaUnited States, France, Belgium, Canada, Poland, Finland, Denmark, Netherlands, Hungary, Italy, Sweden
-
R-BioPusan National University HospitalCompletedCritical Limb IschemiaKorea, Republic of
-
Pharmicell Co., Ltd.Withdrawn
-
Lifecells, LLC.CompletedCritical Limb IschemiaUnited States
-
Neuromed IRCCSUnknown
Clinical Trials on Vein collar at the distal anastomosis
-
University of PatrasTerminatedBrachiobasilic Arteriovenous FistulaGreece
-
Mansoura UniversityUnknown
-
University of BolognaCompletedAdenocarcinoma of the Esophagus | Adenocarcinoma of the Gastric CardiaItaly
-
Memorial Sloan Kettering Cancer CenterCompletedNon-Hodgkin's Lymphoma | CNS Lymphoma | CNS Brain CancerUnited States